LINDSAY DAY: Open Payments
NPI 1619729241 · EVANS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,228 in 72 payments from 22 companies in 2025. Trend: 2023 $0 · 2024 $744 · 2025 $1,228
Food & beverage: $1,228
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 11 | $149 |
| Dexcom, Inc. | 7 | $139 |
| Lilly USA, LLC | 13 | $136 |
| Novartis Pharmaceuticals Corporation | 6 | $128 |
| SANOFI-AVENTIS U.S. LLC | 3 | $84 |
| AstraZeneca Pharmaceuticals LP | 3 | $66 |
| Corcept Therapeutics | 3 | $56 |
| Novo Nordisk Inc | 3 | $52 |
| Phathom Pharmaceuticals, Inc. | 4 | $50 |
| Ionis Pharmaceuticals, Inc. | 2 | $45 |
Products named: Dexcom G6 Transmitter, LEQVIO, MOUNJARO, EVENITY, AIRSUPRA, Korlym, OTEZLA, Ozempic.
Industry payments across GA — which companies pay providers there.
